{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:30:47Z","timestamp":1791307847635,"version":"4.3.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Grants from National Natural Science Foundation of China","award":["81600409"],"award-info":[{"award-number":["81600409"]}]},{"name":"Grants from National Natural Science Foundation of China","award":["81870594"],"award-info":[{"award-number":["81870594"]}]},{"name":"Grants from Shanghai General Hospital","award":["06N1702003"],"award-info":[{"award-number":["06N1702003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00210-024-03485-x","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T08:02:21Z","timestamp":1727769741000},"page":"3681-3695","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["5-aminosalicylic acid alleviates colitis and protects intestinal barrier function by modulating gut microbiota in mice"],"prefix":"10.1007","volume":"398","author":[{"given":"Jingjing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"issue":"1\u20132","key":"3485_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/BF01974941","volume":"21","author":"I Ahnfelt-Ronne","year":"1987","unstructured":"Ahnfelt-Ronne I, Nielsen OH (1987) The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger. Agents Actions 21(1\u20132):191\u2013194","journal-title":"Agents Actions"},{"issue":"7239","key":"3485_CR2","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(62)92080-9","volume":"1","author":"JH Baron","year":"1962","unstructured":"Baron JH, Connell AM, Lennard-Jones JE, Jones FA (1962) Sulphasalazine and salicylazosulphadimidine in ulcerative colitis. Lancet 1(7239):1094\u20131096","journal-title":"Lancet"},{"issue":"8","key":"3485_CR3","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, Alexander H, Alm EJ, Arumugam M, Asnicar F, Bai Y, Bisanz JE, Bittinger K, Brejnrod A, Brislawn CJ, Brown CT, Callahan BJ, Caraballo-Rodriguez AM, Chase J, Cope EK, Da Silva R, Diener C, Dorrestein PC, Douglas GM, Durall DM, Duvallet C, Edwardson CF, Ernst M, Estaki M, Fouquier J, Gauglitz JM, Gibbons SM, Gibson DL, Gonzalez A, Gorlick K, Guo J, Hillmann B, Holmes S, Holste H, Huttenhower C, Huttley GA, Janssen S, Jarmusch AK, Jiang L, Kaehler BD, Kang KB, Keefe CR, Keim P, Kelley ST, Knights D, Koester I, Kosciolek T, Kreps J, Langille MGI, Lee J, Ley R, Liu YX, Loftfield E, Lozupone C, Maher M, Marotz C, Martin BD, McDonald D, McIver LJ, Melnik AV, Metcalf JL, Morgan SC, Morton JT, Naimey AT, Navas-Molina JA, Nothias LF, Orchanian SB, Pearson T, Peoples SL, Petras D, Preuss ML, Pruesse E, Rasmussen LB, Rivers A, Robeson MS 2nd, Rosenthal P, Segata N, Shaffer M, Shiffer A, Sinha R, Song SJ, Spear JR, Swafford AD, Thompson LR, Torres PJ, Trinh P, Tripathi A, Turnbaugh PJ, Ul-Hasan S, van der Hooft JJJ, Vargas F, Vazquez-Baeza Y, Vogtmann E, von Hippel M, Walters W, Wan Y, Wang M, Warren J, Weber KC, Williamson CHD, Willis AD, Xu ZZ, Zaneveld JR, Zhang Y, Zhu Q, Knight R, Caporaso JG (2019) Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol 37(8):852\u2013857","journal-title":"Nat Biotechnol"},{"issue":"3","key":"3485_CR4","first-page":"221","volume":"7","author":"F Casellas","year":"1995","unstructured":"Casellas F, Papo M, Guarner F, Antolin M, Segura RM, Armengol JR, Malagelada JR (1995) Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis. Eur J Gastroenterol Hepatol 7(3):221\u2013226","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3485_CR5","doi-asserted-by":"publisher","unstructured":"Cevallos SA, Lee JY, Velazquez EM, Foegeding NJ, Shelton CD, Tiffany CR, Parry BH, Stull-Lane AR, Olsan EE, Savage HP, Nguyen H, Ghanaat SS, Byndloss AJ, Agu IO, Tsolis RM, Byndloss MX, Baumler AJ (2021) 5-aminosalicylic acid ameliorates colitis and checks dysbiotic Escherichia coli expansion by activating PPAR-gamma signaling in the intestinal epithelium. MBio 12(1). https:\/\/doi.org\/10.1128\/mbio.03227-20","DOI":"10.1128\/mbio.03227-20"},{"key":"3485_CR6","doi-asserted-by":"publisher","first-page":"620724","DOI":"10.3389\/fphar.2020.620724","volume":"11","author":"L Dai","year":"2020","unstructured":"Dai L, Tang Y, Zhou W, Dang Y, Sun Q, Tang Z, Zhu M, Ji G (2020) Gut microbiota and related metabolites were disturbed in ulcerative colitis and partly restored after mesalamine treatment. Front Pharmacol 11:620724","journal-title":"Front Pharmacol"},{"issue":"7405","key":"3485_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature11225","volume":"487","author":"S Devkota","year":"2012","unstructured":"Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB (2012) Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-\/- mice. Nature 487(7405):104\u2013108","journal-title":"Nature"},{"issue":"37","key":"3485_CR8","doi-asserted-by":"publisher","first-page":"26448","DOI":"10.1074\/jbc.274.37.26448","volume":"274","author":"LJ Egan","year":"1999","unstructured":"Egan LJ, Mays DC, Huntoon CJ, Bell MP, Pike MG, Sandborn WJ, Lipsky JJ, McKean DJ (1999) Inhibition of interleukin-1-stimulated NF-kappaB RelA\/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity. J Biol Chem 274(37):26448\u201326453","journal-title":"J Biol Chem"},{"issue":"5","key":"3485_CR9","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/0016-5085(88)90346-0","volume":"95","author":"R Eliakim","year":"1988","unstructured":"Eliakim R, Karmeli F, Razin E, Rachmilewitz D (1988) Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone. Gastroenterology 95(5):1167\u20131172","journal-title":"Gastroenterology"},{"issue":"2","key":"3485_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","volume":"4","author":"EA Franzosa","year":"2019","unstructured":"Franzosa EA, Sirota-Madi A, Avila-Pacheco J, Fornelos N, Haiser HJ, Reinker S, Vatanen T, Hall AB, Mallick H, McIver LJ, Sauk JS, Wilson RG, Stevens BW, Scott JM, Pierce K, Deik AA, Bullock K, Imhann F, Porter JA, Zhernakova A, Fu J, Weersma RK, Wijmenga C, Clish CB, Vlamakis H, Huttenhower C, Xavier RJ (2019) Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol 4(2):293\u2013305","journal-title":"Nat Microbiol"},{"issue":"3","key":"3485_CR11","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.chom.2010.08.004","volume":"8","author":"WS Garrett","year":"2010","unstructured":"Garrett WS, Gallini CA, Yatsunenko T, Michaud M, DuBois A, Delaney ML, Punit S, Karlsson M, Bry L, Glickman JN, Gordon JI, Onderdonk AB, Glimcher LH (2010) Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 8(3):292\u2013300","journal-title":"Cell Host Microbe"},{"key":"3485_CR12","doi-asserted-by":"publisher","first-page":"17004","DOI":"10.1038\/nmicrobiol.2017.4","volume":"2","author":"J Halfvarson","year":"2017","unstructured":"Halfvarson J, Brislawn CJ, Lamendella R, Vazquez-Baeza Y, Walters WA, Bramer LM, D\u2019Amato M, Bonfiglio F, McDonald D, Gonzalez A, McClure EE, Dunklebarger MF, Knight R, Jansson JK (2017) Dynamics of the human gut microbiome in inflammatory bowel disease. Nat Microbiol 2:17004","journal-title":"Nat Microbiol"},{"issue":"11","key":"3485_CR13","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3109\/00365520903262414","volume":"44","author":"Y Hayashi","year":"2009","unstructured":"Hayashi Y, Aoyagi K, Morita I, Yamamoto C, Sakisaka S (2009) Oral administration of mesalazine protects against mucosal injury and permeation in dextran sulfate sodium-induced colitis in rats. Scand J Gastroenterol 44(11):1323\u20131331","journal-title":"Scand J Gastroenterol"},{"issue":"8","key":"3485_CR14","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s00018-022-04471-3","volume":"79","author":"L Huang","year":"2022","unstructured":"Huang L, Zheng J, Sun G, Yang H, Sun X, Yao X, Lin A, Liu H (2022) 5-Aminosalicylic acid ameliorates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota and bile acid metabolism. Cell Mol Life Sci 79(8):460","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"3485_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrd2505","volume":"7","author":"W Jia","year":"2008","unstructured":"Jia W, Li H, Zhao L, Nicholson JK (2008) Gut microbiota: a potential new territory for drug targeting. Nat Rev Drug Discov 7(2):123\u2013129","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"3485_CR16","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/0016-5085(86)90684-0","volume":"91","author":"K Lauritsen","year":"1986","unstructured":"Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J (1986) Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology 91(4):837\u2013844","journal-title":"Gastroenterology"},{"issue":"8","key":"3485_CR17","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1136\/gutjnl-2013-304833","volume":"63","author":"K Machiels","year":"2014","unstructured":"Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, Eeckhaut V, Ballet V, Claes K, Van Immerseel F, Verbeke K, Ferrante M, Verhaegen J, Rutgeerts P, Vermeire S (2014) A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63(8):1275\u20131283","journal-title":"Gut"},{"issue":"2","key":"3485_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41575-020-00399-w","volume":"18","author":"S Mehandru","year":"2021","unstructured":"Mehandru S, Colombel JF (2021) The intestinal barrier, an arbitrator turned provocateur in IBD. Nat Rev Gastroenterol Hepatol 18(2):83\u201384","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"3485_CR19","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41591-023-02217-7","volume":"29","author":"RS Mehta","year":"2023","unstructured":"Mehta RS, Mayers JR, Zhang Y, Bhosle A, Glasser NR, Nguyen LH, Ma W, Bae S, Branck T, Song K, Sebastian L, Pacheco JA, Seo HS, Clish C, Dhe-Paganon S, Ananthakrishnan AN, Franzosa EA, Balskus EP, Chan AT, Huttenhower C (2023) Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease. Nat Med 29(3):700\u2013709","journal-title":"Nat Med"},{"issue":"8","key":"3485_CR20","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1084\/jem.20041948","volume":"201","author":"C Rousseaux","year":"2005","unstructured":"Rousseaux C, Lefebvre B, Dubuquoy L, Lefebvre P, Romano O, Auwerx J, Metzger D, Wahli W, Desvergne B, Naccari GC, Chavatte P, Farce A, Bulois P, Cortot A, Colombel JF, Desreumaux P (2005) Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma. J Exp Med 201(8):1205\u20131215","journal-title":"J Exp Med"},{"issue":"4","key":"3485_CR21","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S0016-5085(19)31672-5","volume":"75","author":"P Sharon","year":"1978","unstructured":"Sharon P, Ligumsky M, Rachmilewitz D, Zor U (1978) Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology 75(4):638\u2013640","journal-title":"Gastroenterology"},{"issue":"8","key":"3485_CR22","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/ibd.20903","volume":"15","author":"H Sokol","year":"2009","unstructured":"Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, Cosnes J, Corthier G, Marteau P, Dore J (2009) Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15(8):1183\u20131189","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"3485_CR23","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1128\/JCM.03128-13","volume":"52","author":"TV Sydenham","year":"2014","unstructured":"Sydenham TV, Arpi M, Klein K, Justesen US (2014) Four cases of bacteremia caused by Oscillibacter ruminantium, a newly described species. J Clin Microbiol 52(4):1304\u20131307","journal-title":"J Clin Microbiol"},{"issue":"10080","key":"3485_CR24","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"389","author":"R Ungaro","year":"2017","unstructured":"Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF (2017) Ulcerative colitis. Lancet 389(10080):1756\u20131770","journal-title":"Lancet"},{"issue":"22","key":"3485_CR25","doi-asserted-by":"publisher","first-page":"11420","DOI":"10.1039\/D1FO01422F","volume":"12","author":"F Wan","year":"2021","unstructured":"Wan F, Han H, Zhong R, Wang M, Tang S, Zhang S, Hou F, Yi B, Zhang H (2021) Dihydroquercetin supplement alleviates colonic inflammation potentially through improved gut microbiota community in mice. Food Funct 12(22):11420\u201311434","journal-title":"Food Funct"},{"issue":"1","key":"3485_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ismej.2014.99","volume":"9","author":"J Wang","year":"2015","unstructured":"Wang J, Tang H, Zhang C, Zhao Y, Derrien M, Rocher E, van-HylckamaVlieg JE, Strissel K, Zhao L, Obin M, Shen J (2015) Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J 9(1):1\u201315","journal-title":"ISME J"},{"key":"3485_CR27","doi-asserted-by":"publisher","first-page":"36137","DOI":"10.1038\/srep36137","volume":"6","author":"JJ Wang","year":"2016","unstructured":"Wang JJ, Wang J, Pang XY, Zhao LP, Tian L, Wang XP (2016a) Sex differences in colonization of gut microbiota from a man with short-term vegetarian and inulin-supplemented diet in germ-free mice. Sci Rep 6:36137","journal-title":"Sci Rep"},{"key":"3485_CR28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bcp.2016.02.019","volume":"106","author":"X Wang","year":"2016","unstructured":"Wang X, Sun Y, Zhao Y, Ding Y, Zhang X, Kong L, Li Z, Guo Q, Zhao L (2016b) Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-kappaB pathway through PPARgamma activation. Biochem Pharmacol 106:70\u201381","journal-title":"Biochem Pharmacol"},{"issue":"37","key":"3485_CR29","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.3748\/wjg.v24.i37.4254","volume":"24","author":"CS Wang","year":"2018","unstructured":"Wang CS, Li WB, Wang HY, Ma YM, Zhao XH, Yang H, Qian JM, Li JN (2018) VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice. World J Gastroenterol 24(37):4254\u20134262","journal-title":"World J Gastroenterol"},{"issue":"8108","key":"3485_CR30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0140-6736(79)90516-6","volume":"1","author":"CP Willoughby","year":"1979","unstructured":"Willoughby CP, Heyworth MF, Piris J, Truelove SC (1979) Comparison of disodium cromoglycate and sulphasalazine as maintenance therapy for ulcerative colitis. Lancet 1(8108):119\u2013122","journal-title":"Lancet"},{"issue":"7","key":"3485_CR31","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/nprot.2017.044","volume":"12","author":"S Wirtz","year":"2017","unstructured":"Wirtz S, Popp V, Kindermann M, Gerlach K, Weigmann B, Fichtner-Feigl S, Neurath MF (2017) Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc 12(7):1295\u20131309","journal-title":"Nat Protoc"},{"key":"3485_CR32","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.3389\/fmicb.2018.01274","volume":"9","author":"J Xu","year":"2018","unstructured":"Xu J, Chen N, Wu Z, Song Y, Zhang Y, Wu N, Zhang F, Ren X, Liu Y (2018) 5-Aminosalicylic acid alters the gut bacterial microbiota in patients with ulcerative colitis. Front Microbiol 9:1274","journal-title":"Front Microbiol"},{"issue":"5","key":"3485_CR33","doi-asserted-by":"publisher","first-page":"e0051822","DOI":"10.1128\/spectrum.00518-22","volume":"10","author":"X Ye","year":"2022","unstructured":"Ye X, Huang D, Dong Z, Wang X, Ning M, Xia J, Shen S, Wu S, Shi Y, Wang J, Wan X (2022) FXR signaling-mediated bile acid metabolism is critical for alleviation of cholesterol gallstones by lactobacillus strains. Microbiol Spectr 10(5):e0051822","journal-title":"Microbiol Spectr"},{"issue":"3","key":"3485_CR34","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41564-019-0649-5","volume":"5","author":"E Zagato","year":"2020","unstructured":"Zagato E, Pozzi C, Bertocchi A, Schioppa T, Saccheri F, Guglietta S, Fosso B, Melocchi L, Nizzoli G, Troisi J, Marzano M, Oresta B, Spadoni I, Atarashi K, Carloni S, Arioli S, Fornasa G, Asnicar F, Segata N, Guglielmetti S, Honda K, Pesole G, Vermi W, Penna G, Rescigno M (2020) Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth. Nat Microbiol 5(3):511\u2013524","journal-title":"Nat Microbiol"},{"issue":"11","key":"3485_CR35","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41429-018-0081-8","volume":"71","author":"S Zhang","year":"2018","unstructured":"Zhang S, Fu J, Dogan B, Scherl EJ, Simpson KW (2018) 5-aminosalicylic acid downregulates the growth and virulence of Escherichia coli associated with IBD and colorectal cancer, and upregulates host anti-inflammatory activity. J Antibiot (Tokyo) 71(11):950\u2013961","journal-title":"J Antibiot (Tokyo)"},{"issue":"7762","key":"3485_CR36","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","volume":"570","author":"M Zimmermann","year":"2019","unstructured":"Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL (2019) Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature 570(7762):462\u2013467","journal-title":"Nature"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03485-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03485-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03485-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:01:43Z","timestamp":1744149703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03485-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3485"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03485-x","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"assertion":[{"value":"9 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were approved by the Animal Ethics Committee of Shanghai General Hospital (2019-A053-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}